How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

Marcy A. List, John Stracks, Laura Colangelo, Pamela Butler, Natasha Ganzenko, Donna Lundy, Paula Sullivan, Daniel Haraf, Merrill Kies, W. Jarrard Goodwin, Everett E. Vokes

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Purpose: To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to ascertain whether patients' preferences are related to demographic or disease characteristics, performance status, or quality of life (QOL). Patients and Methods: One hundred thirty-one patients were assessed pretreatment using standardized measures of QOL (Functional Assessment of Cancer Therapy-Head and Neck) and performance (Performance Status Scale for Head and Neck Cancer). Patients were also asked to rank a series of 12 potential HNC treatment effects. Results: Being cured was ranked top priority by 75% of patients; another 18% ranked it second or third. Living as long as possible and having no pain were placed in the top three by 56% and 35% of patients, respectively. Items that were ranked in the top three by 10% to 24% of patients included those related to energy, swallowing, voice, and appearance. Items related to chewing, being understood, tasting, and dry mouth were placed in the top three by less than 10% of patients. Excluding the top three rankings, there was considerable variability in ratings. Rankings were generally unrelated to patient or disease characteristics, with the exception that cure and living were of slightly lower priority and pain of higher priority to older patients compared with younger patients. Conclusion: The data suggest that, at least pretreatment, survival is of primary importance to patients, supporting the development of aggressive treatment strategies. In addition, results highlight individual variability and warn against making assumptions about patients' attitudes vis-a-vis potential outcomes. Whether patients' priorities will change as they experience late effects is currently under investigation. (C) 2000 American Society of Clinical Oncology.

Original languageEnglish
Pages (from-to)877-884
Number of pages8
JournalJournal of Clinical Oncology
Volume18
Issue number4
StatePublished - Feb 1 2000

Fingerprint

Head and Neck Neoplasms
Therapeutics
Quality of Life
Pain
Survival
Patient Preference
Mastication
Deglutition
Mouth
Demography

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

List, M. A., Stracks, J., Colangelo, L., Butler, P., Ganzenko, N., Lundy, D., ... Vokes, E. E. (2000). How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? Journal of Clinical Oncology, 18(4), 877-884.

How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? / List, Marcy A.; Stracks, John; Colangelo, Laura; Butler, Pamela; Ganzenko, Natasha; Lundy, Donna; Sullivan, Paula; Haraf, Daniel; Kies, Merrill; Goodwin, W. Jarrard; Vokes, Everett E.

In: Journal of Clinical Oncology, Vol. 18, No. 4, 01.02.2000, p. 877-884.

Research output: Contribution to journalArticle

List, MA, Stracks, J, Colangelo, L, Butler, P, Ganzenko, N, Lundy, D, Sullivan, P, Haraf, D, Kies, M, Goodwin, WJ & Vokes, EE 2000, 'How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?', Journal of Clinical Oncology, vol. 18, no. 4, pp. 877-884.
List MA, Stracks J, Colangelo L, Butler P, Ganzenko N, Lundy D et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? Journal of Clinical Oncology. 2000 Feb 1;18(4):877-884.
List, Marcy A. ; Stracks, John ; Colangelo, Laura ; Butler, Pamela ; Ganzenko, Natasha ; Lundy, Donna ; Sullivan, Paula ; Haraf, Daniel ; Kies, Merrill ; Goodwin, W. Jarrard ; Vokes, Everett E. / How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?. In: Journal of Clinical Oncology. 2000 ; Vol. 18, No. 4. pp. 877-884.
@article{23d5e8cb8fcb4eb3a766033edfa8da0c,
title = "How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?",
abstract = "Purpose: To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to ascertain whether patients' preferences are related to demographic or disease characteristics, performance status, or quality of life (QOL). Patients and Methods: One hundred thirty-one patients were assessed pretreatment using standardized measures of QOL (Functional Assessment of Cancer Therapy-Head and Neck) and performance (Performance Status Scale for Head and Neck Cancer). Patients were also asked to rank a series of 12 potential HNC treatment effects. Results: Being cured was ranked top priority by 75{\%} of patients; another 18{\%} ranked it second or third. Living as long as possible and having no pain were placed in the top three by 56{\%} and 35{\%} of patients, respectively. Items that were ranked in the top three by 10{\%} to 24{\%} of patients included those related to energy, swallowing, voice, and appearance. Items related to chewing, being understood, tasting, and dry mouth were placed in the top three by less than 10{\%} of patients. Excluding the top three rankings, there was considerable variability in ratings. Rankings were generally unrelated to patient or disease characteristics, with the exception that cure and living were of slightly lower priority and pain of higher priority to older patients compared with younger patients. Conclusion: The data suggest that, at least pretreatment, survival is of primary importance to patients, supporting the development of aggressive treatment strategies. In addition, results highlight individual variability and warn against making assumptions about patients' attitudes vis-a-vis potential outcomes. Whether patients' priorities will change as they experience late effects is currently under investigation. (C) 2000 American Society of Clinical Oncology.",
author = "List, {Marcy A.} and John Stracks and Laura Colangelo and Pamela Butler and Natasha Ganzenko and Donna Lundy and Paula Sullivan and Daniel Haraf and Merrill Kies and Goodwin, {W. Jarrard} and Vokes, {Everett E.}",
year = "2000",
month = "2",
day = "1",
language = "English",
volume = "18",
pages = "877--884",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "4",

}

TY - JOUR

T1 - How do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

AU - List, Marcy A.

AU - Stracks, John

AU - Colangelo, Laura

AU - Butler, Pamela

AU - Ganzenko, Natasha

AU - Lundy, Donna

AU - Sullivan, Paula

AU - Haraf, Daniel

AU - Kies, Merrill

AU - Goodwin, W. Jarrard

AU - Vokes, Everett E.

PY - 2000/2/1

Y1 - 2000/2/1

N2 - Purpose: To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to ascertain whether patients' preferences are related to demographic or disease characteristics, performance status, or quality of life (QOL). Patients and Methods: One hundred thirty-one patients were assessed pretreatment using standardized measures of QOL (Functional Assessment of Cancer Therapy-Head and Neck) and performance (Performance Status Scale for Head and Neck Cancer). Patients were also asked to rank a series of 12 potential HNC treatment effects. Results: Being cured was ranked top priority by 75% of patients; another 18% ranked it second or third. Living as long as possible and having no pain were placed in the top three by 56% and 35% of patients, respectively. Items that were ranked in the top three by 10% to 24% of patients included those related to energy, swallowing, voice, and appearance. Items related to chewing, being understood, tasting, and dry mouth were placed in the top three by less than 10% of patients. Excluding the top three rankings, there was considerable variability in ratings. Rankings were generally unrelated to patient or disease characteristics, with the exception that cure and living were of slightly lower priority and pain of higher priority to older patients compared with younger patients. Conclusion: The data suggest that, at least pretreatment, survival is of primary importance to patients, supporting the development of aggressive treatment strategies. In addition, results highlight individual variability and warn against making assumptions about patients' attitudes vis-a-vis potential outcomes. Whether patients' priorities will change as they experience late effects is currently under investigation. (C) 2000 American Society of Clinical Oncology.

AB - Purpose: To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to ascertain whether patients' preferences are related to demographic or disease characteristics, performance status, or quality of life (QOL). Patients and Methods: One hundred thirty-one patients were assessed pretreatment using standardized measures of QOL (Functional Assessment of Cancer Therapy-Head and Neck) and performance (Performance Status Scale for Head and Neck Cancer). Patients were also asked to rank a series of 12 potential HNC treatment effects. Results: Being cured was ranked top priority by 75% of patients; another 18% ranked it second or third. Living as long as possible and having no pain were placed in the top three by 56% and 35% of patients, respectively. Items that were ranked in the top three by 10% to 24% of patients included those related to energy, swallowing, voice, and appearance. Items related to chewing, being understood, tasting, and dry mouth were placed in the top three by less than 10% of patients. Excluding the top three rankings, there was considerable variability in ratings. Rankings were generally unrelated to patient or disease characteristics, with the exception that cure and living were of slightly lower priority and pain of higher priority to older patients compared with younger patients. Conclusion: The data suggest that, at least pretreatment, survival is of primary importance to patients, supporting the development of aggressive treatment strategies. In addition, results highlight individual variability and warn against making assumptions about patients' attitudes vis-a-vis potential outcomes. Whether patients' priorities will change as they experience late effects is currently under investigation. (C) 2000 American Society of Clinical Oncology.

UR - http://www.scopus.com/inward/record.url?scp=0033978407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033978407&partnerID=8YFLogxK

M3 - Article

C2 - 10673531

AN - SCOPUS:0033978407

VL - 18

SP - 877

EP - 884

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 4

ER -